TODD STRATEGY GROUP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to the 340B drug discount program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL EDATTEL | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg |
| JEFF LUCAS | Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon |
| TAYLOR SEXTON | Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess |
| DANIEL M TODD | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ctr. - Medicare & Medicaid |
Health Issues HCR
Drug Pricing. COVID-19 Response. General issues related to rare disease and orphan drugs. Reauthorization of the FDA User Fee Act. General issues related to diagnostics for patients with rare diseases. Items related to the Administrations Cancer Moonshot. Prescription Drug User Fee Act (PDUFA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL EDATTEL | — |
| JEFF LUCAS | — |
| TAYLOR SEXTON | — |
| DANIEL M TODD | — |
Medicare/Medicaid MMM
General issues related to patient access to rare disease therapies, Part B and Part D drugs. Issues related to home infusion for Part B patients.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL EDATTEL | — |
| JEFF LUCAS | — |
| TAYLOR SEXTON | — |
| DANIEL M TODD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.